One Drop announced today that its Bluetooth-enabled blood glucose monitoring system and mobile app are now available throughout Canada after landing approval from the country’s regulatory agency.
The company’s portfolio of diabetes management technology is now available in the U.S., Canada, the E.U. and the United Kingdom.
“In delivering the full One Drop experience to Canada, we are offering an essential extension to the Canadian healthcare system, just as we have in the US, EU, and UK,” founder & CEO Jeff Dachis said in prepared remarks. “You cannot improve health outcomes among people with chronic illness without continuous care. With on-demand advice from diabetes experts and data-driven insights served up every day, we’re delivering hyper-personalized care when and where it’s needed most.”
One Drop’s monthly platform includes a diabetes management mobile app, a glucose monitor and test strips, as well as a coaching service for people with diabetes.
The company sells its products using a direct-to-consumer subscription model. Users can subscribe to gain access to One Drop’s products starting at $19.95 per month, according to the company.
“Any diabetes ‘solution’ must drive positive clinical results,” Dachis added. “With One Drop, we are delivering a well-designed, evidence-based diabetes solution that is accessible, affordable, scalable, and effective to anyone, anywhere in the world. In doing so, we reach our goal of empowering everyone with diabetes to make better choices, lead fuller lives, and achieve meaningful improvements in their health.”
Steve MacMillan took over as CEO of Hologic in 2013, drawing on his experience at medtech titans like Stryker and Johnson & Johnson. Since then, Hologic has grown into a $3 billion business.
At DeviceTalks Boston, MacMillan will provide exclusive insights into the Massachusetts-based company and its evolving definition of women's healthcare. You don't want to miss it!
Use code WOMENSHEALTH to save an additional 10%.